Controlled Clinical TrialtaVNS

Accelerated Transcutaneous Auricular Vagus Nerve Stimulation for Inpatient Depression and Anxiety: The iWAVE Open Label Pilot Trial

Austelle CW, Cox SS, Connolly DJ, Baker Vogel B, Peng X, Wills K, Sutton F, Tucker KB, Ashley E, Manett A, et al.

Neuromodulation: Technology at the Neural Interface · 2025

Key finding

Both taVNS dosing approaches were safe and feasible in this novel setting.

Condition
Depression
Stimulation
taVNS
Evidence tier
Controlled Clinical Trial
Participants
View on DOI

Cite this study

Austelle, C. W., Cox, S. S., Connolly, D. J., Baker Vogel, B., Peng, X., Wills, K., Sutton, F., Tucker, K. B., Ashley, E., Manett, A., Cortese, B., Short, E. B., & Badran, B. W. (2025). Accelerated Transcutaneous Auricular Vagus Nerve Stimulation for Inpatient Depression and Anxiety: The iWAVE Open Label Pilot Trial. Neuromodulation: Technology at the Neural Interface, 28(4), 672-681. https://doi.org/10.1016/j.neurom.2025.02.003

Related studies in Depression

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.